Endometrial hyperplasia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
**Age older than 35 years | **Age older than 35 years | ||
**White race | **White race | ||
**Nulliparity | **[[Nulliparity]] | ||
**Late menopause (age > 55) | **Late [[menopause]] (age > 55) | ||
**Early menarche | **Early [[menarche]] | ||
**History of diabetes mellitus, gallbladder disease, or thyroid disease | **History of [[diabetes mellitus]], [[gallbladder]] disease, or [[thyroid]] disease | ||
**Obesity | **Obesity | ||
**Tamoxifen therapy | **[[Tamoxifen]] therapy | ||
**Family history of ovarian, colon, or uterine cancer | **Family history of ovarian, colon, or uterine cancer | ||
**Lynch syndrome | **[[Lynch syndrome]] | ||
==References== | ==References== | ||
Revision as of 13:08, 4 March 2016
|
Endometrial hyperplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial hyperplasia risk factors On the Web |
|
American Roentgen Ray Society Images of Endometrial hyperplasia risk factors |
|
Risk calculators and risk factors for Endometrial hyperplasia risk factors |
Overview
Risk Factors
- Common risk factors in the development of endometrial hyperplasia are:[1]
- Age older than 35 years
- White race
- Nulliparity
- Late menopause (age > 55)
- Early menarche
- History of diabetes mellitus, gallbladder disease, or thyroid disease
- Obesity
- Tamoxifen therapy
- Family history of ovarian, colon, or uterine cancer
- Lynch syndrome
References
- ↑ Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.